|Articles|April 1, 2019
- BioPharm International-04-01-2019
- Volume 32
- Issue 4
BioPharm International, April 2019 Issue (PDF)
Click the title above to open the BioPharm International April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Cleaning Chromatography Resin Residues from Surfacesover 6 years ago
Channeling Customer Complaints into Qualityover 6 years ago
Continuous Manufacturing Gains Major Push from FDAover 6 years ago
Reinventing the Biomanufacturing Wheelover 6 years ago
Continuous Bioprocessing of Vaccinesover 6 years ago
Going Global in Biopharma Regulatory Affairsover 6 years ago
Predictability Improves Prospects for Biopharma Patent Holdersover 6 years ago
What’s New in Downstream ProcessingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
4
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
5
